MYC and cancer: Ochiiwa et al. [79] reported that using TAS4464 (an NAE inhibitor), which is equipped with better selectivity than MLN4924, to treat acute myeloid leukemia (AML) could also cause c-Myc accumulation and the apoptosis of cancer cells to the same extent as MLN4924.